2019
DOI: 10.1371/journal.pone.0217944
|View full text |Cite
|
Sign up to set email alerts
|

Enhancement of binding avidity by bivalent binding enables PrPSc-specific detection by anti-PrP monoclonal antibody 132

Abstract: Anti-prion protein (PrP) monoclonal antibody 132, which recognizes mouse PrP amino acids 119–127, enables us to reliably detect abnormal isoform prion protein (PrP Sc ) in cells or frozen tissue sections by immunofluorescence assay, although treatment with guanidinium salts is a prerequisite. Despite the benefit of this mAb, the mechanism of PrP Sc -specific detection remains unclear. Therefore, to address this mechanism, we analyzed the reactivities of mono- and b… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 47 publications
0
5
0
Order By: Relevance
“…With regard to the association rate constant of IRMAb binding to the IR, the effective k on in vivo is 10 5 M −1 sec −1 (simulation 15, Figure 7), as a k on value of 10 4 M −1 sec −1 (simulation 19, Figure 7) or a k on of 10 6 M −1 sec −1 (simulation 20, Figure 7) produces a predicted brain uptake that is either too low, or too high, respectively, relative to the experimentally observed brain uptake. These estimates of the k on parameter are made in vivo at 37 • C and reflect binding of the MAb to the endothelial membrane-bound receptor, which is expressed at a receptor density, 0.03 fmol/mm 2 (35), that is 100-fold lower than the receptor density used in in vitro SPR experiments [76,77].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…With regard to the association rate constant of IRMAb binding to the IR, the effective k on in vivo is 10 5 M −1 sec −1 (simulation 15, Figure 7), as a k on value of 10 4 M −1 sec −1 (simulation 19, Figure 7) or a k on of 10 6 M −1 sec −1 (simulation 20, Figure 7) produces a predicted brain uptake that is either too low, or too high, respectively, relative to the experimentally observed brain uptake. These estimates of the k on parameter are made in vivo at 37 • C and reflect binding of the MAb to the endothelial membrane-bound receptor, which is expressed at a receptor density, 0.03 fmol/mm 2 (35), that is 100-fold lower than the receptor density used in in vitro SPR experiments [76,77].…”
Section: Discussionmentioning
confidence: 99%
“…However, at the brain endothelial luminal membrane in vivo, the TfRMAb binds to a hetero-tetrameric complex of two Tf molecules bound to a TfR disulfide-linked receptor dimer (Figure 1A), which is embedded in the plasma or endosomal membranes. Second, the TfR1 surface density at the brain capillary in vivo, 0.03 fmol/mm 2 [35], is >100-fold lower than the receptor surface density used in SPR experiments [76,77]. Unknown rate constants were estimated by fitting the mathematical model to experimentally observed brain uptake of the TfRMAb [35].…”
Section: Kinetics Of Bbb Transport Of a Tfrmab In The Rhesus Monkeymentioning
confidence: 99%
“…Genes encoding the N-terminal replaced chimera of rCerPrP and rMoPrP (rMo N –CerPrP, rCer N –MoPrP) were generated using assembly PCR [ 57 ] with primer sets described in the Supplementary Table 2. Genes encoding the C-terminal replaced chimeras (rCer–Mo C PrP, rMo–Cer C PrP) were generated through two consecutive PCRs with primers in Supplementary Table 2.…”
Section: Methodsmentioning
confidence: 99%
“…This new cell-based ELISA can discriminate prion-infected cells from prion-uninfected cells without the need for cell lysate preparation and PK treatment. Such ELISA is a practical and simple method for the primary screening of anti-prion compounds [ 111 , 112 ].…”
Section: The Immunofluorescence Assay (Ifa) Flow Cytometry and Immuno...mentioning
confidence: 99%